Carol Schafer
Directeur/Membre du Conseil chez REPARE THERAPEUTICS INC.
Fortune : 1 M $ au 30/04/2024
Provenance du réseau au premier degré de Carol Schafer
Entité | Type d'entité | Industrie | |
---|---|---|---|
Wells Fargo Securities LLC
Wells Fargo Securities LLC Investment ManagersFinance Wells Fargo Securities LLC (WFS) is the broker/dealer subsidiary of EVEREN Capital Corp., ultimately owned by Wells Fargo & Co. (NYSE: WFC). Headquartered in New York, WFS delivers a comprehensive suite of banking, capital markets and advisory solutions, such as a full complement of sales, trading and research capabilities, to corporate, government and institutional clients.
491
| Subsidiary | Investment Managers | 491 |
J.P. Morgan & Co., Inc. (Old)
197
| Extinct | Regional Banks | 197 |
Public Company | Pharmaceuticals: Major | 23 | |
Public Company | Pharmaceuticals: Major | 19 | |
Subsidiary | Biotechnology | 18 | |
Public Company | Biotechnology | 17 | |
Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc. BiotechnologyHealth Technology Idera Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which focuses on the clinical development, and commercialization of drug candidates for both oncology and rare disease indications. The company was founded by Paul C. Zamecnik, Sudhir A. Agrawal, and James B. Wyngaarden on May 25, 1989 and is headquartered in Exton, PA.
16
| Extinct | Biotechnology | 16 |
Public Company | Biotechnology | 14 | |
Public Company | Pharmaceuticals: Major | 12 | |
Onegoal New York
Onegoal New York Miscellaneous Commercial ServicesCommercial Services Onegoal New York operates a social services organization. The private company is based in New York.
6
| Private Company | Miscellaneous Commercial Services | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Carol Schafer via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing Corporate Officer/Principal Corporate Officer/Principal | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Chief Executive Officer Chief Tech/Sci/R&D Officer Sales & Marketing Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal | |
Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Undergraduate Degree Graduate Degree Masters Business Admin Masters Business Admin | |
BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Founder Chief Operating Officer | |
MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
JPMorgan Securities LLC
JPMorgan Securities LLC Investment ManagersFinance JPMorgan Securities LLC (JPMS) is a securities brokerage firm headquartered in New York City. The firm was founded in 1985 and is a subsidiary of JPMorgan Broker-Dealer Holdings, Inc., ultimately held by JPMorgan Chase & Co., Inc. (NYSE: JPM). JPMS provides research on fixed income, credit, derivatives, emerging markets, foreign exchange, structured finance, technical analysis and bond indices. Their equity analysts cover equities throughout North America, EMEA, Asia/Pacific and the emerging markets. The firm's fixed income team formulates trading and portfolio recommendations for investors in global bonds and other fixed-income markets based on valuations, analytics and market dynamics. | Investment Managers | Analyst-Equity Analyst-Equity Corporate Officer/Principal Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
RECEPTOS INC | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member Chief Tech/Sci/R&D Officer | |
AMGEN INC. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal Sales & Marketing | |
AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | General Counsel Chief Executive Officer Founder | |
Harvard Medical School | College/University | Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
Harvard College | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member Corporate Officer/Principal | |
University of California, Berkeley | College/University | Graduate Degree Undergraduate Degree Doctorate Degree | |
Princeton University | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
ACERAGEN, INC. | Biotechnology | Chairman Director/Board Member Chief Executive Officer | |
MIRATI THERAPEUTICS | Biotechnology | Chairman Director/Board Member | |
Walking Fish Therapeutics, Inc.
Walking Fish Therapeutics, Inc. BiotechnologyHealth Technology Walking Fish Therapeutics, Inc. engages in the provision of immune therapy services. It offers treatment for oncology, rare deficiency disease, regenerative medicine, and infectious disease. The company was founded by Lewis T. Williams, Mark Selby, Seenu Kothakota, and Tom Brennan and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member Chief Executive Officer | |
Advanced Bioconcept Ltd.
Advanced Bioconcept Ltd. Electronic Equipment/InstrumentsElectronic Technology Part of Nen Tm Life Science Products, Inc., Advanced Bioconcept Ltd. is a Canadian company that makes proprietary, fluorescent labeled peptides. The company is based in Montréal, Canada. The company was founded by Clarissa Desjardins. Advanced Bioconcept was acquired by Nen Tm Life Science Products, Inc. on September 25, 1998. | Electronic Equipment/Instruments | Chief Executive Officer Founder | |
Versant Ventures Canada Ltd. | Investment Managers | Private Equity Investor Private Equity Investor | |
Aktis Oncology, Inc.
Aktis Oncology, Inc. Medical/Nursing ServicesHealth Services Aktis Oncology, Inc. is a biotechnology company located in Boston, MA. The company specializes in the discovery and development of a new class of targeted alpha radiopharmaceuticals to treat a broad range of solid tumor cancers. The company's molecules are designed for high tumor penetration and long residence time, which maximizes tumor elimination while minimizing side effects of treatment. The approach enables clinicians to visualize and verify target engagement prior to exposure to therapeutic radioisotopes. Founded and incubated by MPM Capital, Aktis Oncology has developed proprietary platforms to generate tumor targeting agents with ideal properties for alpha radiotherapy. Matt M. Roden has been the CEO of the company since 2020. | Medical/Nursing Services | Director/Board Member Chairman | |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Secretary Director/Board Member | |
Rider University | College/University | Masters Business Admin Masters Business Admin | |
Beckman Coulter, Inc.
Beckman Coulter, Inc. Medical SpecialtiesHealth Technology Beckman Coulter, Inc. manufactures and distributes biomedical testing instrument systems and general biomedical research products. It develops and markets products that simplify, automate and innovate complex biomedical testing. The firm’s systems operate in both diagnostics and life sciences laboratories on seven continents. Its products improve the productivity of medical professionals and scientists, supplying critical information for improving patient health and delivering trusted solutions for research and discovery. The company was founded in 1935 by Arnold O. Beckman and is headquartered in Brea, CA. | Medical Specialties | Director/Board Member Director/Board Member | |
UBS Securities LLC
UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Analyst-Equity Market Strategist | |
GOSSAMER BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | Director/Board Member Director/Board Member | |
OrbiMed Advisors Private Equity
OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor Consultant / Advisor | |
BioNJ, Inc.
BioNJ, Inc. Miscellaneous Commercial ServicesCommercial Services BioNJ, Inc. is based in Trenton, NJ. BioNJ, Inc. is a life sciences trade association with nearly 400 member companies. The company supports the discovery, development, and commercialization of therapies and cures that save and improve lives. BioNJ drives capital formation, fosters entrepreneurship, advocates for medical innovation, provides access to talent and education, and offers critical commercial resources. The company also serves as a clearinghouse for funding information and opportunities. The company was founded in 1994 by James J. Marino, Jayne C. Gershkowitz, Abraham Abuchowski. The CEO is Debbie Hart. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
IKENA ONCOLOGY, INC. | Biotechnology | Director/Board Member Director/Board Member | |
The Trustees of Columbia University in The City of New York | College/University | Masters Business Admin Doctorate Degree | |
AMBIT BIOSCIENCES CORP | Pharmaceuticals: Major | Chairman Director/Board Member | |
BLACK DIAMOND THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Director of Finance/CFO | |
CLEMENTIA PHARMACEUTICALS INC | Pharmaceuticals: Major | Chairman Founder | |
The University of Texas at Austin | College/University | Graduate Degree Corporate Officer/Principal | |
Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
RAYZEBIO, INC. | Biotechnology | Chief Executive Officer Director/Board Member | |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal |
Statistiques
Internationale
Etats-Unis | 45 |
Canada | 5 |
Royaume-Uni | 3 |
Sectorielle
Health Technology | 31 |
Consumer Services | 12 |
Finance | 5 |
Commercial Services | 4 |
Electronic Technology | 2 |
Opérationnelle
Director/Board Member | 522 |
Independent Dir/Board Member | 222 |
Corporate Officer/Principal | 222 |
Undergraduate Degree | 85 |
Chairman | 83 |
Relations les plus connectées
Insiders | |
---|---|
Franklin Berger | 41 |
Kapil Dhingra | 39 |
Todd Foley | 38 |
William Ringo | 32 |
Jerel Davis | 29 |
David Bonita | 27 |
Faheem Hasnain | 27 |
Briggs Morrison | 26 |
Elizabeth Anderson | 25 |
Lewis Williams | 23 |
Robert Hoffman | 22 |
Christine Pellizzari | 22 |
Cristina Csimma | 21 |
Philip Wagenheim | 21 |
Sheila Gujrathi | 20 |
- Bourse
- Insiders
- Carol Schafer
- Connexions Sociétés